EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...
Score will leverage Asimov’s CHO Edge system to accelerate the development of enhanced cancer immunotherapies with improved ADCC activityBOSTON, March 17, 2026 (GLOBE NEWSWIRE) -- Asimov, the ...
Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the expansion at its Glasgow, UK sterile drug product facility as well as ...
AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM for integrating the Leap-In transposase expression platform into its services. With this ...
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
The "Cell Line Characterization and Cell Line Development Market Industry Trends and Global Forecasts to 2035: Distribution by Source of Cell Line / Expression System, Application of Cell Line, ...
Synthetic bio company Asimov agreed to collaborate with Cytiva to provide customers with an integrated offering for optimized biologics production. Access includes Asimov’s CHO Edge cell line ...
Peer-reviewed study demonstrates precision genome editing, stable integration, and high-producing CHO platforms for commercial biomanufacturing LEXINGTON, Ky.--(BUSINESS WIRE)--Demeetra AgBio ...
Think about your favorite medicine. Maybe it is a vaccine or a powerful antibody. Have you ever wondered how it is made? It does not come from a chemical plant. It often comes from living cells.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results